Table of Content

1 Patient In-vivo Dosimetry (IVD) System Market Overview
1.1 Product Overview and Scope of Patient In-vivo Dosimetry (IVD) System
1.2 Patient In-vivo Dosimetry (IVD) System Segment by Type
1.2.1 Global Patient In-vivo Dosimetry (IVD) System Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Portable
1.2.3 Fixed
1.3 Patient In-vivo Dosimetry (IVD) System Segment by Application
1.3.1 Global Patient In-vivo Dosimetry (IVD) System Sales Comparison by Application: (2021-2027)
1.3.2 Medical
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Patient In-vivo Dosimetry (IVD) System Market Size Estimates and Forecasts
1.4.1 Global Patient In-vivo Dosimetry (IVD) System Revenue 2016-2027
1.4.2 Global Patient In-vivo Dosimetry (IVD) System Sales 2016-2027
1.4.3 Patient In-vivo Dosimetry (IVD) System Market Size by Region: 2016 Versus 2021 Versus 2027

2 Patient In-vivo Dosimetry (IVD) System Market Competition by Manufacturers
2.1 Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Manufacturers (2016-2021)
2.2 Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Patient In-vivo Dosimetry (IVD) System Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Patient In-vivo Dosimetry (IVD) System Manufacturing Sites, Area Served, Product Type
2.5 Patient In-vivo Dosimetry (IVD) System Market Competitive Situation and Trends
2.5.1 Patient In-vivo Dosimetry (IVD) System Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Patient In-vivo Dosimetry (IVD) System Players Market Share by Revenue
2.5.3 Global Patient In-vivo Dosimetry (IVD) System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Patient In-vivo Dosimetry (IVD) System Retrospective Market Scenario by Region
3.1 Global Patient In-vivo Dosimetry (IVD) System Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Patient In-vivo Dosimetry (IVD) System Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Patient In-vivo Dosimetry (IVD) System Market Facts & Figures by Country
3.3.1 North America Patient In-vivo Dosimetry (IVD) System Sales by Country
3.3.2 North America Patient In-vivo Dosimetry (IVD) System Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Patient In-vivo Dosimetry (IVD) System Market Facts & Figures by Country
3.4.1 Europe Patient In-vivo Dosimetry (IVD) System Sales by Country
3.4.2 Europe Patient In-vivo Dosimetry (IVD) System Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Patient In-vivo Dosimetry (IVD) System Market Facts & Figures by Region
3.5.1 Asia Pacific Patient In-vivo Dosimetry (IVD) System Sales by Region
3.5.2 Asia Pacific Patient In-vivo Dosimetry (IVD) System Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Patient In-vivo Dosimetry (IVD) System Market Facts & Figures by Country
3.6.1 Latin America Patient In-vivo Dosimetry (IVD) System Sales by Country
3.6.2 Latin America Patient In-vivo Dosimetry (IVD) System Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Patient In-vivo Dosimetry (IVD) System Market Facts & Figures by Country
3.7.1 Middle East and Africa Patient In-vivo Dosimetry (IVD) System Sales by Country
3.7.2 Middle East and Africa Patient In-vivo Dosimetry (IVD) System Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Patient In-vivo Dosimetry (IVD) System Historic Market Analysis by Type
4.1 Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2016-2021)
4.2 Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Type (2016-2021)
4.3 Global Patient In-vivo Dosimetry (IVD) System Price by Type (2016-2021)

5 Global Patient In-vivo Dosimetry (IVD) System Historic Market Analysis by Application
5.1 Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2016-2021)
5.2 Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Application (2016-2021)
5.3 Global Patient In-vivo Dosimetry (IVD) System Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Landauer
6.1.1 Landauer Corporation Information
6.1.2 Landauer Description and Business Overview
6.1.3 Landauer Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Landauer Patient In-vivo Dosimetry (IVD) System Product Portfolio
6.1.5 Landauer Recent Developments/Updates
6.2 Chiyoda Technol Corporation
6.2.1 Chiyoda Technol Corporation Corporation Information
6.2.2 Chiyoda Technol Corporation Description and Business Overview
6.2.3 Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Product Portfolio
6.2.5 Chiyoda Technol Corporation Recent Developments/Updates
6.3 Mirion Technologies
6.3.1 Mirion Technologies Corporation Information
6.3.2 Mirion Technologies Description and Business Overview
6.3.3 Mirion Technologies Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Mirion Technologies Patient In-vivo Dosimetry (IVD) System Product Portfolio
6.3.5 Mirion Technologies Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Corporation Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Fuji Electric
6.5.1 Fuji Electric Corporation Information
6.5.2 Fuji Electric Description and Business Overview
6.5.3 Fuji Electric Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Fuji Electric Patient In-vivo Dosimetry (IVD) System Product Portfolio
6.5.5 Fuji Electric Recent Developments/Updates
6.6 Hitachi Aloka
6.6.1 Hitachi Aloka Corporation Information
6.6.2 Hitachi Aloka Description and Business Overview
6.6.3 Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Product Portfolio
6.6.5 Hitachi Aloka Recent Developments/Updates
6.7 Bertin Instruments
6.6.1 Bertin Instruments Corporation Information
6.6.2 Bertin Instruments Description and Business Overview
6.6.3 Bertin Instruments Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bertin Instruments Patient In-vivo Dosimetry (IVD) System Product Portfolio
6.7.5 Bertin Instruments Recent Developments/Updates
6.8 Tracerco
6.8.1 Tracerco Corporation Information
6.8.2 Tracerco Description and Business Overview
6.8.3 Tracerco Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Tracerco Patient In-vivo Dosimetry (IVD) System Product Portfolio
6.8.5 Tracerco Recent Developments/Updates
6.9 ATOMTEX
6.9.1 ATOMTEX Corporation Information
6.9.2 ATOMTEX Description and Business Overview
6.9.3 ATOMTEX Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
6.9.4 ATOMTEX Patient In-vivo Dosimetry (IVD) System Product Portfolio
6.9.5 ATOMTEX Recent Developments/Updates
6.10 Panasonic
6.10.1 Panasonic Corporation Information
6.10.2 Panasonic Description and Business Overview
6.10.3 Panasonic Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Panasonic Patient In-vivo Dosimetry (IVD) System Product Portfolio
6.10.5 Panasonic Recent Developments/Updates
6.11 Polimaster
6.11.1 Polimaster Corporation Information
6.11.2 Polimaster Patient In-vivo Dosimetry (IVD) System Description and Business Overview
6.11.3 Polimaster Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Polimaster Patient In-vivo Dosimetry (IVD) System Product Portfolio
6.11.5 Polimaster Recent Developments/Updates
6.12 Renri
6.12.1 Renri Corporation Information
6.12.2 Renri Patient In-vivo Dosimetry (IVD) System Description and Business Overview
6.12.3 Renri Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Renri Patient In-vivo Dosimetry (IVD) System Product Portfolio
6.12.5 Renri Recent Developments/Updates
6.13 RadPro International GmbH
6.13.1 RadPro International GmbH Corporation Information
6.13.2 RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Description and Business Overview
6.13.3 RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
6.13.4 RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Product Portfolio
6.13.5 RadPro International GmbH Recent Developments/Updates
6.14 Ludlum Measurements
6.14.1 Ludlum Measurements Corporation Information
6.14.2 Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Description and Business Overview
6.14.3 Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Product Portfolio
6.14.5 Ludlum Measurements Recent Developments/Updates
6.15 XZ LAB
6.15.1 XZ LAB Corporation Information
6.15.2 XZ LAB Patient In-vivo Dosimetry (IVD) System Description and Business Overview
6.15.3 XZ LAB Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
6.15.4 XZ LAB Patient In-vivo Dosimetry (IVD) System Product Portfolio
6.15.5 XZ LAB Recent Developments/Updates

7 Patient In-vivo Dosimetry (IVD) System Manufacturing Cost Analysis
7.1 Patient In-vivo Dosimetry (IVD) System Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Patient In-vivo Dosimetry (IVD) System
7.4 Patient In-vivo Dosimetry (IVD) System Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Patient In-vivo Dosimetry (IVD) System Distributors List
8.3 Patient In-vivo Dosimetry (IVD) System Customers

9 Patient In-vivo Dosimetry (IVD) System Market Dynamics
9.1 Patient In-vivo Dosimetry (IVD) System Industry Trends
9.2 Patient In-vivo Dosimetry (IVD) System Growth Drivers
9.3 Patient In-vivo Dosimetry (IVD) System Market Challenges
9.4 Patient In-vivo Dosimetry (IVD) System Market Restraints

10 Global Market Forecast
10.1 Patient In-vivo Dosimetry (IVD) System Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Patient In-vivo Dosimetry (IVD) System by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Patient In-vivo Dosimetry (IVD) System by Type (2022-2027)
10.2 Patient In-vivo Dosimetry (IVD) System Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Patient In-vivo Dosimetry (IVD) System by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Patient In-vivo Dosimetry (IVD) System by Application (2022-2027)
10.3 Patient In-vivo Dosimetry (IVD) System Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Patient In-vivo Dosimetry (IVD) System by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Patient In-vivo Dosimetry (IVD) System by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Patient In-vivo Dosimetry (IVD) System Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Patient In-vivo Dosimetry (IVD) System Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Patient In-vivo Dosimetry (IVD) System Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Patient In-vivo Dosimetry (IVD) System Covered in This Study
Table 5. Global Patient In-vivo Dosimetry (IVD) System Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Patient In-vivo Dosimetry (IVD) System Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Patient In-vivo Dosimetry (IVD) System Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Patient In-vivo Dosimetry (IVD) System Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Patient In-vivo Dosimetry (IVD) System Manufacturing Sites and Area Served
Table 11. Manufacturers Patient In-vivo Dosimetry (IVD) System Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Patient In-vivo Dosimetry (IVD) System by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Patient In-vivo Dosimetry (IVD) System as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Patient In-vivo Dosimetry (IVD) System Sales by Region (2016-2021) & (K Units)
Table 16. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Region (2016-2021)
Table 17. Global Patient In-vivo Dosimetry (IVD) System Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Patient In-vivo Dosimetry (IVD) System Sales by Country (2016-2021) & (K Units)
Table 19. North America Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country (2016-2021)
Table 20. North America Patient In-vivo Dosimetry (IVD) System Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country (2016-2021)
Table 22. Europe Patient In-vivo Dosimetry (IVD) System Sales by Country (2016-2021) & (K Units)
Table 23. Europe Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country (2016-2021)
Table 24. Europe Patient In-vivo Dosimetry (IVD) System Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Patient In-vivo Dosimetry (IVD) System Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Patient In-vivo Dosimetry (IVD) System Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Patient In-vivo Dosimetry (IVD) System Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Region (2016-2021)
Table 30. Latin America Patient In-vivo Dosimetry (IVD) System Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country (2016-2021)
Table 32. Latin America Patient In-vivo Dosimetry (IVD) System Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Patient In-vivo Dosimetry (IVD) System Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Patient In-vivo Dosimetry (IVD) System Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Patient In-vivo Dosimetry (IVD) System Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Country (2016-2021)
Table 38. Global Patient In-vivo Dosimetry (IVD) System Sales (K Units) by Type (2016-2021)
Table 39. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2016-2021)
Table 40. Global Patient In-vivo Dosimetry (IVD) System Revenue (Million US$) by Type (2016-2021)
Table 41. Global Patient In-vivo Dosimetry (IVD) System Revenue Share by Type (2016-2021)
Table 42. Global Patient In-vivo Dosimetry (IVD) System Price (US$/Unit) by Type (2016-2021)
Table 43. Global Patient In-vivo Dosimetry (IVD) System Sales (K Units) by Application (2016-2021)
Table 44. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2016-2021)
Table 45. Global Patient In-vivo Dosimetry (IVD) System Revenue (Million US$) by Application (2016-2021)
Table 46. Global Patient In-vivo Dosimetry (IVD) System Revenue Share by Application (2016-2021)
Table 47. Global Patient In-vivo Dosimetry (IVD) System Price (US$/Unit) by Application (2016-2021)
Table 48. Landauer Corporation Information
Table 49. Landauer Description and Business Overview
Table 50. Landauer Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Landauer Patient In-vivo Dosimetry (IVD) System Product
Table 52. Landauer Recent Developments/Updates
Table 53. Chiyoda Technol Corporation Corporation Information
Table 54. Chiyoda Technol Corporation Description and Business Overview
Table 55. Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Product
Table 57. Chiyoda Technol Corporation Recent Developments/Updates
Table 58. Mirion Technologies Corporation Information
Table 59. Mirion Technologies Description and Business Overview
Table 60. Mirion Technologies Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Mirion Technologies Patient In-vivo Dosimetry (IVD) System Product
Table 62. Mirion Technologies Recent Developments/Updates
Table 63. Thermo Fisher Scientific Corporation Information
Table 64. Thermo Fisher Scientific Description and Business Overview
Table 65. Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Product
Table 67. Thermo Fisher Scientific Recent Developments/Updates
Table 68. Fuji Electric Corporation Information
Table 69. Fuji Electric Description and Business Overview
Table 70. Fuji Electric Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Fuji Electric Patient In-vivo Dosimetry (IVD) System Product
Table 72. Fuji Electric Recent Developments/Updates
Table 73. Hitachi Aloka Corporation Information
Table 74. Hitachi Aloka Description and Business Overview
Table 75. Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Product
Table 77. Hitachi Aloka Recent Developments/Updates
Table 78. Bertin Instruments Corporation Information
Table 79. Bertin Instruments Description and Business Overview
Table 80. Bertin Instruments Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Bertin Instruments Patient In-vivo Dosimetry (IVD) System Product
Table 82. Bertin Instruments Recent Developments/Updates
Table 83. Tracerco Corporation Information
Table 84. Tracerco Description and Business Overview
Table 85. Tracerco Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Tracerco Patient In-vivo Dosimetry (IVD) System Product
Table 87. Tracerco Recent Developments/Updates
Table 88. ATOMTEX Corporation Information
Table 89. ATOMTEX Description and Business Overview
Table 90. ATOMTEX Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. ATOMTEX Patient In-vivo Dosimetry (IVD) System Product
Table 92. ATOMTEX Recent Developments/Updates
Table 93. Panasonic Corporation Information
Table 94. Panasonic Description and Business Overview
Table 95. Panasonic Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Panasonic Patient In-vivo Dosimetry (IVD) System Product
Table 97. Panasonic Recent Developments/Updates
Table 98. Polimaster Corporation Information
Table 99. Polimaster Description and Business Overview
Table 100. Polimaster Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Polimaster Patient In-vivo Dosimetry (IVD) System Product
Table 102. Polimaster Recent Developments/Updates
Table 103. Renri Corporation Information
Table 104. Renri Description and Business Overview
Table 105. Renri Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Renri Patient In-vivo Dosimetry (IVD) System Product
Table 107. Renri Recent Developments/Updates
Table 108. RadPro International GmbH Corporation Information
Table 109. RadPro International GmbH Description and Business Overview
Table 110. RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Product
Table 112. RadPro International GmbH Recent Developments/Updates
Table 113. Ludlum Measurements Corporation Information
Table 114. Ludlum Measurements Description and Business Overview
Table 115. Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Product
Table 117. Ludlum Measurements Recent Developments/Updates
Table 118. XZ LAB Corporation Information
Table 119. XZ LAB Description and Business Overview
Table 120. XZ LAB Patient In-vivo Dosimetry (IVD) System Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. XZ LAB Patient In-vivo Dosimetry (IVD) System Product
Table 122. XZ LAB Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Patient In-vivo Dosimetry (IVD) System Distributors List
Table 126. Patient In-vivo Dosimetry (IVD) System Customers List
Table 127. Patient In-vivo Dosimetry (IVD) System Market Trends
Table 128. Patient In-vivo Dosimetry (IVD) System Growth Drivers
Table 129. Patient In-vivo Dosimetry (IVD) System Market Challenges
Table 130. Patient In-vivo Dosimetry (IVD) System Market Restraints
Table 131. Global Patient In-vivo Dosimetry (IVD) System Sales Forecast by Type (2022-2027) & (K Units)
Table 132. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share Forecast by Type (2022-2027)
Table 133. Global Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 134. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share Forecast by Type (2022-2027)
Table 135. Global Patient In-vivo Dosimetry (IVD) System Sales Forecast by Application (2022-2027) & (K Units)
Table 136. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share Forecast by Application (2022-2027)
Table 137. Global Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 138. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share Forecast by Application (2022-2027)
Table 139. Global Patient In-vivo Dosimetry (IVD) System Sales Forecast by Region (2022-2027) & (K Units)
Table 140. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share Forecast by Region (2022-2027)
Table 141. Global Patient In-vivo Dosimetry (IVD) System Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 142. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share Forecast by Region (2022-2027)
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Patient In-vivo Dosimetry (IVD) System
Figure 2. Global Patient In-vivo Dosimetry (IVD) System Market Share by Type in 2020 & 2027
Figure 3. Portable Product Picture
Figure 4. Fixed Product Picture
Figure 5. Global Patient In-vivo Dosimetry (IVD) System Market Share by Application in 2020 & 2027
Figure 6. Medical
Figure 7. Scientific Research
Figure 8. Others
Figure 9. Global Patient In-vivo Dosimetry (IVD) System Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Patient In-vivo Dosimetry (IVD) System Market Size 2016-2027 (US$ Million)
Figure 11. Global Patient In-vivo Dosimetry (IVD) System Sales 2016-2027 (K Units)
Figure 12. Global Patient In-vivo Dosimetry (IVD) System Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Patient In-vivo Dosimetry (IVD) System Sales Share by Manufacturers in 2020
Figure 14. Global Patient In-vivo Dosimetry (IVD) System Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Patient In-vivo Dosimetry (IVD) System Players: Market Share by Revenue in 2020
Figure 16. Patient In-vivo Dosimetry (IVD) System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Region (2016-2021)
Figure 18. Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Region in 2020
Figure 19. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Region (2016-2021)
Figure 20. Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Region in 2020
Figure 21. United States Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Taiwan Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Turkey Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Saudi Arabia Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. UAE Patient In-vivo Dosimetry (IVD) System Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Sales Market Share of Patient In-vivo Dosimetry (IVD) System by Type (2016-2021)
Figure 44. Sales Market Share of Patient In-vivo Dosimetry (IVD) System by Application (2016-2021)
Figure 45. Sales Market Share of Patient In-vivo Dosimetry (IVD) System by Application in 2020
Figure 46. Revenue Share of Patient In-vivo Dosimetry (IVD) System by Application (2016-2021)
Figure 47. Revenue Share of Patient In-vivo Dosimetry (IVD) System by Application in 2020
Figure 48. Manufacturing Cost Structure of Patient In-vivo Dosimetry (IVD) System
Figure 49. Manufacturing Process Analysis of Patient In-vivo Dosimetry (IVD) System
Figure 50. Patient In-vivo Dosimetry (IVD) System Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed